The Institute generates news every day. Some findings are groundbreaking—some represent smaller steps. But ultimately, it is the combination of both that makes scientific advancement possible. Here is a little selection of the latest stories making it out to the wider world.
In a recent article published in nature reviews immunology, LIT scientists, Dr. Jeremy G. Baldwin, Dr. Christoph Heuser-Loy, and Prof. Luca Gattinoni, provide an update on the latest advances in our understanding of how organelles govern T-cell function and how this knowledge can be leveraged to improve the therapeutic efficacy of cancer immunotherapies.
On Tuesday, October 7, Prof. Philipp Beckhove opened the exhibition of paintings by Prof. Stefan Rüdiger with a festive vernissage: Bright colors shine against a dark blue backdrop in the foyer of the main entrance at Regensburg University Hospital, encouraging visitors to learn about current Alzheimer’s research. The exhibition is open to the public until October 29, and admission is free of charge.
The Nobel Commitee awarded the 2025 Nobel Prize in Physiology or Medicine to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi for their groundbreaking discoveries related to peripheral immune tolerance.
In a recent article published in “Nature Reviews Gastroenterology & Hepatology”, LIT scientist Prof. Hinrich Abken comprehensively reviews the state-of-the art in chimeric antigen receptor (CAR) T cell therapy in gastrointestinal tumors and discusses challenges and emerging solutions to overcome treatment resistance of solid tumors. This overview is especially important for oncologists, immunologists, and medical researchers interested in cellular therapies against cancer.
The LIT proudly presents the exhibition „Alzheimer’s Research Meets Art“ in Regensburg – an Art Exhibition inspired by the Biomedical Research by Prof. Stefan Rüdiger from 08th October 2025 – 29th October 2025.
In July, Ruth Waldmann, a member of the Bavarian State Parliament for the SPD and representing the district of Upper Bavaria, visited the LIT in Regensburg, accompanied by her team. Discussions with the LIT’s Scientific Director, Prof. Philipp Beckhove, focused on scientific innovations, public funding, and the future of research in Germany.
In a recent article published in “Der Internist” (German), LIT scientists Dr. Markus Barden, Dr. Astrid Holzinger, and Prof. Hinrich Abken comprehensively review the challenges and emerging solutions for chimeric antigen receptor (CAR) T cell therapy in solid tumors. This overview is especially important for oncologists, immunologists, and medical researchers interested in cellular therapies against cancer.
Gabriele Inchingolo, Ph.D. student in Prof. Luca Gattinoni’s lab at the Leibniz Institute for Immunotherapy, has been selected as one of the winners of Bruker’s inaugural Beacon Discovery Global Grant Program.
From May 18 to June 7, 2025, Desireé Fest, apprentice in the LIT’s administration, embarked on an exciting international experience in Dublin as part of the Erasmus+ internship program. Selected by her vocational school, Desireé took part in this valuable exchange opportunity that combined professional development with cultural immersion.
The LIT Retreat took place on July 28 and 29, 2025 at Haus Bayerischer Wald in Lam.
